<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03351673</url>
  </required_header>
  <id_info>
    <org_study_id>Endometrial volume</org_study_id>
    <nct_id>NCT03351673</nct_id>
  </id_info>
  <brief_title>Endometrial Volume as a Predictor of Endometrial Pathology in Perimenopausal Uterine Bleeding Endometrial Volume as a Predictor of Endometrial Pathology in Perimenopausal Uterine Bleeding</brief_title>
  <official_title>Endometrial Volume as a Predictor of Endometrial Pathology in Perimenopausal Uterine Bleeding Endometrial Volume as a Predictor of Endometrial Pathology in Perimenopausal Uterine Bleeding</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Endometrial thickness has been used as an indicator of risk for endometrial hyperplasia and
      carcinoma in asymptomatic perimenopausal women. However, there is no cutoff value in
      perimenopausal women and the same thickness does not express the same endometrial volume in
      different endometrium because uterine lengths may be different and endometrial irregularities
      may exist. Many studies assessed endometrial volume measured by three-dimensional (3D) TVS as
      a predictor of malignancy in women with postmenopausal bleeding. To our knowledge there is no
      study assess endometrial volume measured by two dimension TVS in prediction of endometrial
      pathology, however it is cheap and available than 3D TVS.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 8, 2017</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>accuracy of measurement of endometrial volume by 2D TVS in prediction of endometrial pathology</measure>
    <time_frame>1year</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Endometrial Disorder</condition>
  <arm_group>
    <arm_group_label>endometrial volume 2D TVS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>perimenopausal women who bleed are examined by 2D TVS and the calculated endometrial volume using a specific formula and followed by endometrial biopsy for correlation with the pathological findings</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>endometrial volume 2D TVS</intervention_name>
    <description>calculation the endometrial volume using 2D ultrasound and correlation the results with the pathological findings of endometrial biopsy</description>
    <arm_group_label>endometrial volume 2D TVS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        *perimenopausal women with abnormal bleeding e.g. menorrhagia, metrorrhagia and
        polymenorrhea.

        Exclusion Criteria:

        *general or local causes of bleeding, drug intake or recent hormonal contraception
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hanan Nabil, MD</last_name>
    <phone>002/01000571004</phone>
    <email>hanannobil00@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Waleed Elrefaie, MD</last_name>
    <phone>002/01224515318</phone>
    <email>wrefaie@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>mansoura University</name>
      <address>
        <city>Mansourah</city>
        <state>Dakahlia</state>
        <zip>35516</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>hanan nabil, MD</last_name>
      <phone>00201000571004</phone>
      <email>hanannobil00@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>waleed Elrefaie, MD</last_name>
      <phone>00201224515318</phone>
      <email>wrefaie@yahoo.com</email>
    </contact_backup>
    <investigator>
      <last_name>Mahmoud Abdelrazik, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 20, 2017</study_first_submitted>
  <study_first_submitted_qc>November 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 24, 2017</study_first_posted>
  <last_update_submitted>November 22, 2017</last_update_submitted>
  <last_update_submitted_qc>November 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Hanan Nabil</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Uterine Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

